secwatch.observer — SEC 8-K summary
======================================

Issuer:     CITIUS ONCOLOGY, INC. (CTOR)
CIK:        0001851484
Form:       8-K
Filed at:   2026-05-06T23:59:59+00:00
Accession:  0001213900-26-052552
Event type: debt
Sentiment:  positive
Materiality: 0.75
Item codes: 1.01, 2.03, 3.02, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Citius Oncology secures up to $36.5M in debt and warrant exercise proceeds
--------------------------------------------------------------------------

- Warrant inducement yields ~$11.5M gross from exercise of 12.8M shares at $0.90; new warrants for 25.6M shares at $0.90.
- Avenue Capital Group provides up to $25M senior secured credit facility; $10M initial tranche funded at close.
- Avenue also receives warrants to buy up to 11.1M shares at $0.90 exercisable after stockholder approval.
- Parent debt subordinated to new loan; promissory note amended to align with 91-day post-Senior Debt maturity.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1851484/000121390026052552/0001213900-26-052552-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1851484/000121390026052552/ea0289297-8k_citius.htm
  HTML page:      https://secwatch.observer/filing/0001213900-26-052552

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer